CAR-T cell therapy: Materials
Critical materials
The materials whose supply could hold it back
- No commodity material limits CAR-T: the bottleneck is making each patient's cells, which takes about 3 to 5 weeks [1].
- Manufacturing is concentrated in a few specialised plants, such as Novartis's site in Morris Plains, New Jersey, for Kymriah [3].
as of 2026-11-11
Sources
- CAR T Cells: Engineering Patients' Immune Cells to Treat Their Cancers National Cancer Institute (NIH), 2025
- FDA Approves Novartis' CAR-T Drug, First Gene Therapy Approval in US Pharmaceutical Technology, 2017